- Home
- COLL vs PRSU Comparison
COLL vs PRSU Comparison
Compare COLL & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLL | PRSU |
|---|---|---|
| Founded | 2002 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 946.6M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | COLL | PRSU |
|---|---|---|
| Price | $32.40 | $35.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $51.17 | $31.67 |
| AVG Volume (30 Days) | ★ 547.7K | 220.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.73 | N/A |
| Revenue | ★ $780,567,000.00 | N/A |
| Revenue This Year | $5.93 | $4.85 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | $19.32 | ★ $3.45 |
| Revenue Growth | ★ 23.62 | N/A |
| 52 Week Low | $23.23 | $26.90 |
| 52 Week High | $50.79 | $38.33 |
Technical Indicators
Market Signals| Indicator | COLL | PRSU |
|---|---|---|
| Relative Strength Index (RSI) | 24.32 | 45.89 |
| Support Level | $31.01 | $32.73 |
| Resistance Level | $32.92 | $37.75 |
| Average True Range (ATR) | 1.30 | 1.22 |
| MACD | -0.04 | -0.11 |
| Stochastic Oscillator | 1.07 | 37.61 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
About PRSU Pursuit Attractions and Hospitality Inc.
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.